Page last updated: 2024-09-04

levofloxacin and ethambutol

levofloxacin has been researched along with ethambutol in 57 studies

Compound Research Comparison

Studies (levofloxacin)	Trials (levofloxacin)	Recent Studies (post-2010) (levofloxacin)	Studies (ethambutol)	Trials (ethambutol)	Recent Studies (post-2010) (ethambutol)
4,346	581	2,209	4,454	366	1,143

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (8.77)	18.2507
2000's	9 (15.79)	29.6817
2010's	30 (52.63)	24.3611
2020's	13 (22.81)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Camacho-Corona, MDR; Favela-Hernández, JMJ; García, A; Garza-González, E; Miranda, LD; Reyes-Melo, K; Rivas-Galindo, VM; Romo-Mancillas, A; Vargas-Villarreal, J	1
Abay, E; Axtman, M; Ballell, L; Barry, CE; Boesche, M; Boshoff, HIM; Brunschwig, C; Chibale, K; Drewes, G; Gessner, RK; Ghidelli-Disse, S; Ghorpade, SR; Gordon, R; Harris, CJ; Lafuente-Monasterio, MJ; Lawrence, N; Lelièvre, J; Mizrahi, V; Moosa, A; Mueller, R; Nchinda, A; Njoroge, M; Pflaumer, H; Rebollo-Lopez, MJ; Santos, G; Sanz, O; Seldon, R; Selenski, C; Simelane, SB; Sirgel, FA; Soares de Melo, C; Street, LJ; Taylor, D; Urones, B; van Helden, P; Warner, DF; Wilson, CR	1
Ahmad, Z; Amin, S; Bhat, BA; Bhat, ZS; Dar, MJ; Lone, AM; Maqbool, M; Rather, MA; Shairgojray, BA; Singh, P; Teli, B; Yousuf, SK	1
Ahmad, Z; Ara, T; Bhat, ZS; Maqbool, M; Rather, MA; Ul Lah, H; Yousuf, SK	1
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D	1
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W	1
Bera, S; Mondal, D	1
Mabhula, A; Singh, V	1
Aguirre-Rentería, SA; Arredondo-Espinoza, E; Avalos-Alanís, FG; Carrizales-Castillo, JJJ; Del Rayo Camacho Corona, M; Garza-González, E; Hernández-Fernández, E; Rivas-Galindo, VM	1
Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M	1
Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R	1
Bermudez, LE; Kolonoski, P; Young, LS	1
Barbara-Burnham, L; Bermudez, LE; Inderlied, CB; Kolonoski, P; Wu, M; Young, LS	1
Bryskier, A; Devallois, A; Goh, KS; Rastogi, N	1
Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE	1
Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE	1
Cheon, SH; Dietze, R; Ellner, JJ; Hise, AG; Landen, K; Palaci, M; Phillips, M; Ribeiro, FC; Song, HY; Vinhas, S; Wallis, RS	1
Brade, V; Enzensberger, R; Gruschke, A	1
Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA	1
Bhusal, Y; Shiohira, CM; Yamane, N	1
Chen, YC; Ho, CC; Hu, FC; Luh, KT; Yang, PC; Yu, CJ	1
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A	1
Hagiwara, E; Komatsu, S; Ogura, T; Sawahata, M; Sekine, A; Takahashi, H; Tsuchiya, N	1
Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA	1
Akçalı, A; Akman, T; Değirmenci, Y; Karatağ, O; Koşar, S; Sener, A	1
Aboud, C; Algood, H; Boyd, AS; Braun, N; Burke, VE; Drake, WP; Isom, J; Kaminski, N; King, LE; Oswald-Richter, K; Pandit, KV; Richmond, BW; Taylor, T; Yu, C	1
Denno, K; Horiki, M; Minoda, Y; Tada, K; Yano, K; Yoneda, M; Yoshida, T	1
Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A	1
Caleffi-Ferracioli, KR; Cardoso, RF; Maltempe, FG; Siqueira, VL	1
Behera, C; Krishna, K; Singh, HR	1
Bhoi, SK; Kalita, J; Misra, UK; Prasad, S	1
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V	1
Arai, M	1
Betai, S; Bhoi, SK; Kalita, J; Misra, UK	1
Choi, JH; Heo, NY; Jo, KM; Kim, WG; Nam, KH; Park, CS; Park, SH	1
Chu, N; Duan, H; Huang, H; Jing, W; Zeng, X; Zhang, Y	1
Du, J; Gao, J; Gao, M; Li, L; Liu, Y; Ma, L; Mi, F; Tang, S; Zhang, Y	1
Krokowski, S; Larrouy-Maumus, G; Lobato-Márquez, D; Mostowy, S; Pennisi, I; Rebollo-Ramirez, S; Thomson, M	1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y	1
Alarcón Guizado, VA; Alarcon, E; Cornejo Garcia, JG; Heldal, E; Mendoza Ticona, A; Moore, DAJ	1
Abbara, A; Abubakar, I; Alexander, E; Booth, H; Bothamley, GH; Creer, DD; Davidson, JA; Harris, RJ; Kon, OM; Kunst, H; Lalor, MK; Lipman, MC; Loebinger, MR; Loutet, MG; Lozewicz, S; McHugh, TD; Milburn, HJ; Mohiyuddin, T; Palchaudhuri, P; Phillips, PPJ; Schmok, E; Stagg, HR; Taylor, L	1
Eather, G; Matigian, N; O'Connor, B; Wilson, M	1
Abel, K; Ayers, GD; Baughman, RP; Bernard, GR; Crouser, ED; Culver, DA; Ding, T; Drake, WP; Green, A; James, WE; Judson, MA; Kerrigan, A; Sesay, A	1
Chaudhary, S; Garg, V; Maji, S; Singh, V	1
Arenivas, A; Balaji, S; Devaleenal D, B; Dooley, KE; Gadama, D; Giridharan, P; Gupta, A; Gupte, N; Inamdar, S; Khwaja, S; Kinikar, A; Mave, V; Mvalo, T; Nimkar, S; Paradkar, MS; Savic, R; Selladurai, E; Swaminathan, S; Thakur, KT; Valvi, C; Venkatesan, M; Wolf, L; Yadav Kattagoni, K	1
Jiang, H; Li, X; Niu, Q; Xing, Z; Xu, J	1
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN	1
Chen, KH; Chen, YL; Hung, CC; Lin, SW; Liu, WD; Wang, JT; Wang, YC	1
Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N	1
Hsiao, HC; Jou, R; Wu, SH; Xiao, YX	1
Aalhoul, F; Cotton, F; Fage, D	1

Reviews

5 review(s) available for levofloxacin and ethambutol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Insights of synthetic analogues of anti-leprosy agents. Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13 Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship	2019
Drug-resistance in MedChemComm, 2019, Aug-01, Volume: 10, Issue:8 Topics:	2019
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:9 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis	2010
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:11 Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2010

Trials

9 trial(s) available for levofloxacin and ethambutol

Article	Year
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica AIDS (London, England), 1997, Volume: 11, Issue:12 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis	1997
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	1998
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult	2011
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA dermatology, 2013, Volume: 149, Issue:9 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Azithromycin; CD4-Positive T-Lymphocytes; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Sarcoidosis; Severity of Illness Index; Single-Blind Method; Skin Diseases; Transcriptome; Treatment Outcome; Young Adult	2013
Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspirin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Prednisolone; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult	2014
Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study. Tuberculosis (Edinburgh, Scotland), 2016, Volume: 98 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Disability Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Pyrazinamide; Rifampin; Seizures; Time Factors; Treatment Outcome; Tuberculosis, Meningeal; Young Adult	2016
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014. PloS one, 2018, Volume: 13, Issue:12 Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Levofloxacin; Male; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Time Factors; Tuberculosis, Multidrug-Resistant	2018
Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis. Chest, 2021, Volume: 159, Issue:5 Topics: Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Levofloxacin; Male; Middle Aged; Respiratory Function Tests; Rifabutin; Sarcoidosis, Pulmonary	2021
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9 Topics: Adult; Antitubercular Agents; Child; Ethambutol; Humans; Levofloxacin; Rifampin; Standard of Care; Tuberculosis, Meningeal	2022

Other Studies

43 other study(ies) available for levofloxacin and ethambutol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin	2010
meso-Dihydroguaiaretic acid derivatives with antibacterial and antimycobacterial activity. Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20 Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Guaiacol; Lignans; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Vero Cells	2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies. Journal of medicinal chemistry, 2017, 12-28, Volume: 60, Issue:24 Topics: Administration, Oral; Animals; Antitubercular Agents; Blood Proteins; Drug Stability; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Mycobacterium tuberculosis; Proteomics; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship	2017
The synthesis, biological evaluation and structure-activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents. MedChemComm, 2017, Nov-01, Volume: 8, Issue:11 Topics:	2017
Synthesis and MedChemComm, 2018, Jan-01, Volume: 9, Issue:1 Topics:	2018
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis. European journal of medicinal chemistry, 2019, Feb-15, Volume: 164 Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2019
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II. Journal of medicinal chemistry, 2019, 04-11, Volume: 62, Issue:7 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells	2019
Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from l-serine. Bioorganic & medicinal chemistry letters, 2020, 05-01, Volume: 30, Issue:9 Topics: Animals; Antineoplastic Agents; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Serine; Vero Cells	2020
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. European journal of medicinal chemistry, 2021, Feb-15, Volume: 212 Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship	2021
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy. Bioorganic & medicinal chemistry, 2022, 06-15, Volume: 64 Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells	2022
Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4 Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Colony Count, Microbial; Drug Combinations; Ethambutol; Levofloxacin; Mice; Mycobacterium avium; Ofloxacin; Roxithromycin; Spleen; Tuberculosis	1996
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3 Topics: Animals; Anti-Infective Agents; Cell Line; Drug Combinations; Ethambutol; Female; Fluoroquinolones; Humans; Levofloxacin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rats	1996
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Drug Combinations; Ethambutol; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin	1996
A whole blood bactericidal assay for tuberculosis. The Journal of infectious diseases, 2001, Apr-15, Volume: 183, Issue:8 Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Blood; Blood Bactericidal Activity; Culture Media; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Quinolines; Rifampin	2001
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-20, Volume: 127, Issue:38 Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Osteomyelitis; Recurrence; Rifabutin; Tibia	2002
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2002, Volume: 33, Issue:3 Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis	2002
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. International journal of antimicrobial agents, 2005, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis	2005
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jun-01, Volume: 48, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Antitubercular Agents; Aspartate Aminotransferases; Aza Compounds; Ethambutol; Female; Fluoroquinolones; Hepatic Insufficiency; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Streptomycin; Treatment Outcome; Tuberculosis; Young Adult	2009
[Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol]. Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4 Topics: Antitubercular Agents; Cervical Vertebrae; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Epidural Abscess; Ethambutol; Humans; Isoniazid; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thoracic Vertebrae; Tuberculosis, Central Nervous System	2012
Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs. Journal of plastic surgery and hand surgery, 2013, Volume: 47, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Hand Strength; Humans; Immunocompetence; Isoniazid; Levofloxacin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium marinum; Osteomyelitis; Range of Motion, Articular; Retrospective Studies; Rifampin; Scaphoid Bone; Synovectomy; Tenosynovitis	2013
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India. Tropical medicine & international health : TM & IH, 2013, Volume: 18, Issue:9 Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis	2013
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method. Tuberculosis (Edinburgh, Scotland), 2013, Volume: 93, Issue:6 Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Oxazines; Tuberculosis; Tuberculosis, Multidrug-Resistant; Xanthenes	2013
Antitubercular drug-induced violent suicide of a hospitalised patient. BMJ case reports, 2014, Jan-06, Volume: 2014 Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Ethambutol; Heart Injuries; Hospitalization; Humans; India; Levofloxacin; Male; Psychoses, Substance-Induced; Self-Injurious Behavior; Suicide; Tuberculosis, Multidrug-Resistant; Violence; Wounds, Stab; Young Adult	2014
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab. The Indian journal of tuberculosis, 2014, Volume: 61, Issue:4 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult	2014
[A case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents]. Rinsho shinkeigaku = Clinical neurology, 2015, Volume: 55, Issue:2 Topics: Antitubercular Agents; Drug Hypersensitivity; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Immunologic Tests; Isoniazid; Levofloxacin; Lymphocyte Activation; Male; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Meningeal	2015
[Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2016, May-25, Volume: 67, Issue:5 Topics: Alanine Transaminase; Antitubercular Agents; Cycloserine; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Eosinophilia; Ethambutol; Female; Hepatitis, Autoimmune; Humans; Isoniazid; Levofloxacin; Liver; Prothionamide; Severity of Illness Index; Tuberculosis; Young Adult	2016
Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:2 Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Genotype; Genotyping Techniques; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Sputum	2017
Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial. BMC infectious diseases, 2017, 06-19, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary	2017
Intact Cell Lipidomics Reveal Changes to the Ratio of Cardiolipins to Phosphatidylinositols in Response to Kanamycin in HeLa and Primary Cells. Chemical research in toxicology, 2018, 08-20, Volume: 31, Issue:8 Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Cardiolipins; Dose-Response Relationship, Drug; Ethambutol; HeLa Cells; Humans; Kanamycin; Levofloxacin; Lipid Metabolism; Membrane Potentials; Mice; Mitochondria; Phosphatidylinositols; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9 Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. The European respiratory journal, 2019, Volume: 54, Issue:4 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Logistic Models; London; Male; Middle Aged; Practice Guidelines as Topic; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult	2019
Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series. Respiratory medicine, 2020, Volume: 173 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Australia; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethinyl Estradiol-Norgestrel Combination; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2020
Isolated multidrug-resistant tubercular tenosynovitis of the flexor tendon of the little finger. BMJ case reports, 2021, Feb-19, Volume: 14, Issue:2 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Resistance, Multiple; Ethambutol; Female; Fingers; Humans; Levofloxacin; Linezolid; Magnetic Resonance Imaging; Tendons; Tenosynovitis; Tuberculosis; Young Adult	2021
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant Current drug delivery, 2023, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prothionamide; Pyrazinamide; Reactive Oxygen Species; Tuberculosis; Tuberculosis, Multidrug-Resistant	2023
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru. BMC infectious diseases, 2022, Aug-24, Volume: 22, Issue:1 Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant	2022
Pyrazinamide related prolonged drug-induced liver injury: A case report. Medicine, 2022, Sep-30, Volume: 101, Issue:39 Topics: Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Levofloxacin; Pyrazinamide; Transaminases; Tuberculosis, Lymph Node	2022
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen. The American journal of case reports, 2022, Oct-10, Volume: 23 Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis	2022
Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs. Microbiology spectrum, 2022, 12-21, Volume: 10, Issue:6 Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant	2022
Protein binding investigation of first-line and second-line antituberculosis drugs. International journal of antimicrobial agents, 2023, Volume: 62, Issue:6 Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Moxifloxacin; Protein Binding; Pyrazinamide; Rifampin; Tuberculosis	2023